1. Home
  2. CCCC vs TCX Comparison

CCCC vs TCX Comparison

Compare CCCC & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.39

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$15.64

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
TCX
Founded
2015
1992
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
197.3M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
CCCC
TCX
Price
$2.39
$15.64
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.6M
30.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
$362,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
6.76
52 Week Low
$1.09
$13.27
52 Week High
$3.82
$25.17

Technical Indicators

Market Signals
Indicator
CCCC
TCX
Relative Strength Index (RSI) 44.03 37.43
Support Level $2.31 $15.50
Resistance Level $2.52 $22.15
Average True Range (ATR) 0.20 0.78
MACD -0.07 0.15
Stochastic Oscillator 0.00 23.58

Price Performance

Historical Comparison
CCCC
TCX

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

Share on Social Networks: